Apetrei C, Iancu L, Pânzaru C, Gheorghiu R, Bosnea D, Sumuciuc I, Duca M
Laboratorul de Virologie, Universitatea de Medicină şi Farmacie Iaşi.
Rev Med Chir Soc Med Nat Iasi. 1993 Jan-Mar;97(1):467-72.
Our study consist of 1082 patients with acute respiratory disease or their contacts. Antigens prepared at "Cantacuzino Institute", C.D.C. Atlanta and from viral strains isolated in our laboratory were used. Hemagglutination-inhibiting Test was preceded by the elimination of the unspecific inhibitors with IO4K M/90. Significant titers were considered those > 1/10.
Were assessed by determining the number of antibody carriers, their ratio and geometrical mean of the reciprocal value of H.I. antibody titers.
我们的研究包括1082例急性呼吸道疾病患者或其接触者。使用了在“坎塔库齐诺研究所”、美国疾病控制与预防中心(亚特兰大)制备的抗原以及从我们实验室分离的病毒株。在进行血凝抑制试验之前,先用IO4K M/90消除非特异性抑制剂。滴度>1/10被视为有显著意义。
通过确定抗体携带者的数量、比例以及血凝抑制抗体滴度倒数的几何平均值来进行评估。